NR 601 Week 2 with 33 complete
solutions.
NR 601 Week 2 with 33 complete
solutions.
Asthma - symptoms - ANSWER shortness of breath, wheezing, coughing especially at night, chest
tightness
asthma - contributing factors - ANSWER exposure to allergens, respiratory infections, family history /
genetic predisposition, occupational irritants, tobacco smoke, indoor and outdoor pollution, obesity
asthma - normal FEV1 / FVC - ANSWER 8-9 yr 85%
20-39 yr 80%
40-59 yr 75%
60-80 yr 70%
asthma - classification of severity - ANSWER intermittent: <or= 2 days / week
mild: <2 days/wk but not daily
moderate: daily
severe: throughout the day
asthma - treatment - ANSWER step 1: SABS prn
step 2: low dose ICS
step 3: low dose ICS + LABA; or medium dose ICS
step 4: medium dose ICS + LABA
step 5: high dose ICS + LABA and omlizumab for patients with allergies
step 6: high dose ICS + LABA + oral corticosteroid and omlizumab for patients with allergies
cardiac arrhythmias - symptoms - ANSWER heart beating out of chest; palpitations, sinkable episodes,
extra heart sounds
, NR 601 Week 2 with 33 complete
solutions.
arrhythmia - prevalent forms and geriatric population - ANSWER 1. sick sinus syndrome- Brady-
tachycardia syndrome, SVT
2. atrial arrhythmias
3. arrhythmias within the AV node
4. arrhythmias partially super ventricular in origin
5. ventricular arrhythmias
COPD - symptoms - ANSWER dyspnea, chronic cough, sputum, wheezing, decrease activity tolerance
COPD-Classification of Severity - ANSWER FEV1/FVC ratio <0.70 AND
Gold 1 (mild): FEV1 >80% predicted
Gold 2 (mod): 50% <FEV1 <80%predicted
Gold 3 (sev): 30% <FEV1 <50% predicted
Gold 4 (very sev): FEV1 <30% predicted
COPD assessment tools - ANSWER COPD Assessment Test (CAT)
Clinical COPD Questionnaire (CCQ)
mMRC Breathlessness scale
COPD prevention of exacerbation - ANSWER ✔️smoking cessation
✔️reduce exposure to environmental and occupational risk factors
✔️influenza vaccine
✔️pneumococcal vaccine
solutions.
NR 601 Week 2 with 33 complete
solutions.
Asthma - symptoms - ANSWER shortness of breath, wheezing, coughing especially at night, chest
tightness
asthma - contributing factors - ANSWER exposure to allergens, respiratory infections, family history /
genetic predisposition, occupational irritants, tobacco smoke, indoor and outdoor pollution, obesity
asthma - normal FEV1 / FVC - ANSWER 8-9 yr 85%
20-39 yr 80%
40-59 yr 75%
60-80 yr 70%
asthma - classification of severity - ANSWER intermittent: <or= 2 days / week
mild: <2 days/wk but not daily
moderate: daily
severe: throughout the day
asthma - treatment - ANSWER step 1: SABS prn
step 2: low dose ICS
step 3: low dose ICS + LABA; or medium dose ICS
step 4: medium dose ICS + LABA
step 5: high dose ICS + LABA and omlizumab for patients with allergies
step 6: high dose ICS + LABA + oral corticosteroid and omlizumab for patients with allergies
cardiac arrhythmias - symptoms - ANSWER heart beating out of chest; palpitations, sinkable episodes,
extra heart sounds
, NR 601 Week 2 with 33 complete
solutions.
arrhythmia - prevalent forms and geriatric population - ANSWER 1. sick sinus syndrome- Brady-
tachycardia syndrome, SVT
2. atrial arrhythmias
3. arrhythmias within the AV node
4. arrhythmias partially super ventricular in origin
5. ventricular arrhythmias
COPD - symptoms - ANSWER dyspnea, chronic cough, sputum, wheezing, decrease activity tolerance
COPD-Classification of Severity - ANSWER FEV1/FVC ratio <0.70 AND
Gold 1 (mild): FEV1 >80% predicted
Gold 2 (mod): 50% <FEV1 <80%predicted
Gold 3 (sev): 30% <FEV1 <50% predicted
Gold 4 (very sev): FEV1 <30% predicted
COPD assessment tools - ANSWER COPD Assessment Test (CAT)
Clinical COPD Questionnaire (CCQ)
mMRC Breathlessness scale
COPD prevention of exacerbation - ANSWER ✔️smoking cessation
✔️reduce exposure to environmental and occupational risk factors
✔️influenza vaccine
✔️pneumococcal vaccine
